ACI
GSK icon

Alpha Cubed Investments’s GSK GSK Stock Holding History

Alpha Cubed Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,873
Closed -$320K – 289
2022
Q2 		$320K Sell
5,873
-108
-2% -$5.96K 0.02% 227
2022
Q1 		$326K Buy
+5,981
New +$325K 0.02% 247
2018
Q4 		– Sell
-12,926
Closed -$660K – 266
2018
Q3 		$660K Buy
+12,926
New +$657K 0.08% 136

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Alpha Cubed Investments's GSK Position: Q3 2022 in Review

Alpha Cubed Investments sold out of GSK (GSK) in Q3 2022, closing a stake of 5,873 shares — an estimated $320K sold.

Alpha Cubed Investments first reported a position in GSK in Q3 2018 and held it in 3 quarters. The position peaked at $660K in Q3 2018. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Alpha Cubed Investments reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • Alpha Cubed Investments sold 5,873 GSK shares in Q3 2022, an estimated $320K.
  • Alpha Cubed Investments first reported a position in GSK in Q3 2018 and held it in 3 quarters.
  • Alpha Cubed Investments's GSK position peaked at $660K in Q3 2018.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Alpha Cubed Investments's 13F filing for Q3 2022, filed 4 Nov 2022.